BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Nectar Lifescience Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
532649
ISIN Demat
INE023H01027
Book Value (Rs)
36.7483544
NSE Symbol
NECLIFE
Divident Yield %
0
Market Cap
(Rs In Cr.)
280
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
1
Back
Nectar Lifescience reports consolidated net loss of Rs 176.01 crore in the September 2025 quarter
15-Nov-25   Hrs IST

Net loss of Nectar Lifescience reported to Rs 176.01 crore in the quarter ended September 2025 as against net profit of Rs 5.60 crore during the previous quarter ended September 2024. Sales declined 12.74% to Rs 5.00 crore in the quarter ended September 2025 as against Rs 5.73 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales5.005.73 -13
OPM %-6.60-10.30 -
PBDT-0.300.10 PL
PBT-0.50-0.35 -43
NP-176.015.60 PL

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)